Probiotics Market by Ingredient (Bacteria, Yeast), Application (Food & Beverages, Dietary Supplements, Animal Feed), Function (Regular, Preventative Healthcare, Therapeutic) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Probiotics are microorganisms, such as bacteria and yeast, that are very useful to sustain the balance of intestinal microbial in human and animal body. Probiotic ingredients stimulate natural digestive juices and enzymes in the body to ensure proper functioning of the digestive system. In addition, probiotics protect healthy organisms from harmful microorganisms. Nowadays, probiotic products find applications to diagnose mental illness and treat digestive problems & neurological disorders. Moreover, they strengthen the human immune system, protect proteins & lipids from oxidative destruction, and reduce body pathogens. Probiotic ingredients can be administered through food or in the form of supplements. In addition, these ingredients are sold in the form of capsules, tablets, powders, and gel.
The major factor that boosts the market growth is increase in consumer preference for natural products. Rise in concerns of consumers on preventive healthcare and effectiveness of probiotic bacteria on health drive the market growth. The demand of probiotics has increased due to upsurge in consumption of functional foods, which have potentially positive effects on health apart from providing basic nutrition. Besides, factors such as ban on the usage of antibiotics in animal feed in several countries, increase in product innovations in the form of chocolates, biscuits & others, increased demand of probiotic based medicines for chronic diseases such as diarrhea & bowel diseases drives the market growth. In addition, increase in disposable income and improved standards of living in developing economies supplement the market growth.
The factors that restrict the market growth are lack of standardization regarding microorganism concentration in probiotic products, high prices of ingredients and lack of awareness regarding benefits of probiotics among consumers. Proactive government support such as approval from Food & Drug Administration for probiotic dietary supplements & Foods for Specific Health Uses are expected to offer lucrative opportunities for market growth. Also, several publications on probiotics, functional food fact sheets, and conferences by International Food Information Council (IFIC) have increased awareness about probiotic products, which are expected to drive the market.
The world probiotics market is segmented based on ingredient, application, function, end use, and geography. Based on ingredient, the market is segmented into bacteria and yeast. Probiotic foods such as Yogurt and Kefirs are induced with probiotic bacteria either in powdered or liquid form. Yeast probiotics are used for therapeutic purposes also. Bacterial strains are available in powdered, liquid, and in gel forms whereas yeast strains are available only in powdered form. Bacteria segment accounted for the maximum revenue share in the year 2014 and is anticipated to consolidate its position during the forecast period, owing to its health benefits such as improve lactose digestion, prevention of urogenital infections, and treatment of allergies.
Based on application, the market is segmented into food & beverages, dietary supplements, and animal feed. Food & beverages is the most preferred mode of consumption of probiotics and is expected to maintain its dominance during the forecast period. Dietary supplements segment is expected to be the fastest growing segment during the forecast period, due to rise in demand for botanical and natural health supplements, which will help maintain good gut health and strong immune system.
Based on function, the market is divided into regular, preventive healthcare, and therapeutic. Among these, preventive healthcare function is expected to grow with a highest growth rate due to rise in application in pharmaceutical industry to regulate the digestion and normalize the intestinal tract. By end use, the probiotics market is segmented into animal probiotics and human probiotics. Human probiotics dominated the overall probiotics market in 2014 and this segment is anticipated to generate highest revenue throughout the forecast period.
The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA along with their prominent respective countries. Asia-Pacific would continue to be the highest revenue-generating region during the forecast period. Factors such as rapid growth in the food & beverage industry in developing countries, such as India and China, and rise in awareness of benefits of probiotic food products drive the market. The key players operating in this market include BioGaia AB, Danone, Chr. Hansen Holding A/S, Yakult Honsha Co., Ltd., Probi AB, Lifeway Foods, Inc., Nestle S.A., Ganeden, Inc., E. I. du Pont de Nemours and Company, and Protexin.
KEY BENEFITS
By Ingredient
The major factor that boosts the market growth is increase in consumer preference for natural products. Rise in concerns of consumers on preventive healthcare and effectiveness of probiotic bacteria on health drive the market growth. The demand of probiotics has increased due to upsurge in consumption of functional foods, which have potentially positive effects on health apart from providing basic nutrition. Besides, factors such as ban on the usage of antibiotics in animal feed in several countries, increase in product innovations in the form of chocolates, biscuits & others, increased demand of probiotic based medicines for chronic diseases such as diarrhea & bowel diseases drives the market growth. In addition, increase in disposable income and improved standards of living in developing economies supplement the market growth.
The factors that restrict the market growth are lack of standardization regarding microorganism concentration in probiotic products, high prices of ingredients and lack of awareness regarding benefits of probiotics among consumers. Proactive government support such as approval from Food & Drug Administration for probiotic dietary supplements & Foods for Specific Health Uses are expected to offer lucrative opportunities for market growth. Also, several publications on probiotics, functional food fact sheets, and conferences by International Food Information Council (IFIC) have increased awareness about probiotic products, which are expected to drive the market.
The world probiotics market is segmented based on ingredient, application, function, end use, and geography. Based on ingredient, the market is segmented into bacteria and yeast. Probiotic foods such as Yogurt and Kefirs are induced with probiotic bacteria either in powdered or liquid form. Yeast probiotics are used for therapeutic purposes also. Bacterial strains are available in powdered, liquid, and in gel forms whereas yeast strains are available only in powdered form. Bacteria segment accounted for the maximum revenue share in the year 2014 and is anticipated to consolidate its position during the forecast period, owing to its health benefits such as improve lactose digestion, prevention of urogenital infections, and treatment of allergies.
Based on application, the market is segmented into food & beverages, dietary supplements, and animal feed. Food & beverages is the most preferred mode of consumption of probiotics and is expected to maintain its dominance during the forecast period. Dietary supplements segment is expected to be the fastest growing segment during the forecast period, due to rise in demand for botanical and natural health supplements, which will help maintain good gut health and strong immune system.
Based on function, the market is divided into regular, preventive healthcare, and therapeutic. Among these, preventive healthcare function is expected to grow with a highest growth rate due to rise in application in pharmaceutical industry to regulate the digestion and normalize the intestinal tract. By end use, the probiotics market is segmented into animal probiotics and human probiotics. Human probiotics dominated the overall probiotics market in 2014 and this segment is anticipated to generate highest revenue throughout the forecast period.
The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA along with their prominent respective countries. Asia-Pacific would continue to be the highest revenue-generating region during the forecast period. Factors such as rapid growth in the food & beverage industry in developing countries, such as India and China, and rise in awareness of benefits of probiotic food products drive the market. The key players operating in this market include BioGaia AB, Danone, Chr. Hansen Holding A/S, Yakult Honsha Co., Ltd., Probi AB, Lifeway Foods, Inc., Nestle S.A., Ganeden, Inc., E. I. du Pont de Nemours and Company, and Protexin.
KEY BENEFITS
- This report provides an in-depth analysis of the world probiotics market to elucidate the potential investment pockets.
- The current trends and future scenarios are outlined to determine the overall market potential and single out profitable trends to gain a stronger foothold in the market.
- This report provides information regarding key drivers, restraints, and opportunities along with their detailed impact analysis.
- Quantitative analysis of the current market trends and estimations for the period of 2014–2022 are provided to indicate its financial competency.
- Porters Five Forces Model of the industry illustrate the potency of buyers and suppliers.
- Value chain analysis provides a clear understanding on the roles of stakeholders in the industry.
By Ingredient
- Bacteria
- Yeast
- Regular
- Preventive Healthcare
- Therapeutic
- Food & Beverage
- Dietary Supplements
- Animal Feed
- Human Probiotics
- Animal Probiotics
- North America
- U.S.
- Mexico
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Rest of Europe (The Netherlands, Spain, Turkey and others)
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific (Singapore, Australia, Thailand, and others)
- LAMEA
- Latin America
- Middle East
- Africa
- Yakult Honsha Co., Ltd.
- BioGaia AB
- Danone
- E. I. du Pont de Nemours and Company
- Probi AB
- Ganeden, Inc.
- Protexin
- Nestle S.A.
- Chr. Hansen Holding A/S
- Lifeway Foods, Inc.
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top winning strategies
3.2.3 Top investment pockets
3.3 Porter’s Five forces analysis
3.3.1 Growing number of market players results in moderate bargaining power of buyers
3.3.2 Limited number of quality raw material suppliers increases the bargaining power of suppliers
3.3.3 Well established industry giants and huge investment limits the emergence of new entrants
3.3.4 Lack of viable substitute leads to low threat of substitutes
3.3.5 Well-established brands and growing market lead to moderate rivalry among competitors
3.4 Value chain analysis
3.5 Market share analysis, 2015
3.6 Market dynamics
3.6.1 Drivers
3.6.1.1 Growing health concerns
3.6.1.2 Rising consumption of functional foods
3.6.1.3 Increasing investment on research & development
3.6.2 Restraints
3.6.2.1 Low awareness level among consumers about effectiveness of probiotic products
3.6.2.2 Government regulations
3.6.3 Opportunities
3.6.3.1 Rising demand of probiotic products in developing nations
3.6.3.2 Creating awareness about the benefits of probiotics
CHAPTER 4 WORLD PROBIOTICS MARKET, BY INGREDIENT
4.1 Overview
4.1.1 Market size and forecast
4.2 Bacteria
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Yeast
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
CHAPTER 5 WORLD PROBIOTICS MARKET, BY FUNCTION
5.1 Overview
5.1.1 Market size and forecast
5.2 Regular
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Preventative healthcare
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Therapeutic
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
CHAPTER 6 WORLD PROBIOTICS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Food & Beverage
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Dietary supplements
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 Animal feed
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
CHAPTER 7 WORLD PROBIOTICS MARKET, BY END USE
7.1 Overview
7.1.1 Market size and forecast
7.2 Human probiotics
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Animal probiotics
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
CHAPTER 8 WORLD PROBIOTICS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.3.1 U.S.
8.2.3.2 Mexico
8.2.3.3 Canada
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.3.1 UK
8.3.3.2 Germany
8.3.3.3 France
8.3.3.4 Italy
8.3.3.5 Rest of Europe
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.3.1 China
8.4.3.2 Japan
8.4.3.3 India
8.4.3.4 Rest of Asia-Pacific
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.3.1 Latin America
8.5.3.2 Middle East
8.5.3.3 Africa
CHAPTER 9 COMPANY PROFILE
9.1 Yakult Honsha Co., Ltd.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business performance
9.1.4 Operating business segments
9.1.5 Strategic moves & developments
9.2 BioGaia AB
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Operating business segments
9.2.5 Strategic moves & developments
9.3 Danone
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Operating business segments
9.3.5 Strategic moves & developments
9.4 E. I. du Pont de Nemours and Company
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Business performance
9.4.5 Strategic moves & developments
9.5 Probi AB
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Operating business segments
9.5.5 Strategic moves & developments
9.6 Ganeden, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Strategic moves and developments
9.7 Protexin
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Strategic moves and developments
9.8 Nestle S.A.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business performance
9.8.4 Operating business segments
9.8.5 Strategic moves and developments
9.9 Chr. Hansen Holding A/S
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Business performance
9.9.4 Operating business segments
9.9.5 Strategic moves and developments
9.10 Lifeway Foods, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Business performance
9.10.4 Operating business segments
9.10.5 Strategic moves and developments
List of Figures
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top winning strategies
3.2.3 Top investment pockets
3.3 Porter’s Five forces analysis
3.3.1 Growing number of market players results in moderate bargaining power of buyers
3.3.2 Limited number of quality raw material suppliers increases the bargaining power of suppliers
3.3.3 Well established industry giants and huge investment limits the emergence of new entrants
3.3.4 Lack of viable substitute leads to low threat of substitutes
3.3.5 Well-established brands and growing market lead to moderate rivalry among competitors
3.4 Value chain analysis
3.5 Market share analysis, 2015
3.6 Market dynamics
3.6.1 Drivers
3.6.1.1 Growing health concerns
3.6.1.2 Rising consumption of functional foods
3.6.1.3 Increasing investment on research & development
3.6.2 Restraints
3.6.2.1 Low awareness level among consumers about effectiveness of probiotic products
3.6.2.2 Government regulations
3.6.3 Opportunities
3.6.3.1 Rising demand of probiotic products in developing nations
3.6.3.2 Creating awareness about the benefits of probiotics
CHAPTER 4 WORLD PROBIOTICS MARKET, BY INGREDIENT
4.1 Overview
4.1.1 Market size and forecast
4.2 Bacteria
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Yeast
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
CHAPTER 5 WORLD PROBIOTICS MARKET, BY FUNCTION
5.1 Overview
5.1.1 Market size and forecast
5.2 Regular
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Preventative healthcare
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Therapeutic
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
CHAPTER 6 WORLD PROBIOTICS MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Food & Beverage
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Dietary supplements
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 Animal feed
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
CHAPTER 7 WORLD PROBIOTICS MARKET, BY END USE
7.1 Overview
7.1.1 Market size and forecast
7.2 Human probiotics
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Animal probiotics
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
CHAPTER 8 WORLD PROBIOTICS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.3.1 U.S.
8.2.3.2 Mexico
8.2.3.3 Canada
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.3.1 UK
8.3.3.2 Germany
8.3.3.3 France
8.3.3.4 Italy
8.3.3.5 Rest of Europe
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.3.1 China
8.4.3.2 Japan
8.4.3.3 India
8.4.3.4 Rest of Asia-Pacific
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.3.1 Latin America
8.5.3.2 Middle East
8.5.3.3 Africa
CHAPTER 9 COMPANY PROFILE
9.1 Yakult Honsha Co., Ltd.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business performance
9.1.4 Operating business segments
9.1.5 Strategic moves & developments
9.2 BioGaia AB
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Operating business segments
9.2.5 Strategic moves & developments
9.3 Danone
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Operating business segments
9.3.5 Strategic moves & developments
9.4 E. I. du Pont de Nemours and Company
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Business performance
9.4.5 Strategic moves & developments
9.5 Probi AB
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Operating business segments
9.5.5 Strategic moves & developments
9.6 Ganeden, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Strategic moves and developments
9.7 Protexin
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Strategic moves and developments
9.8 Nestle S.A.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business performance
9.8.4 Operating business segments
9.8.5 Strategic moves and developments
9.9 Chr. Hansen Holding A/S
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Business performance
9.9.4 Operating business segments
9.9.5 Strategic moves and developments
9.10 Lifeway Foods, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Business performance
9.10.4 Operating business segments
9.10.5 Strategic moves and developments
List of Figures
LIST OF TABLES
TABLE 1 WORLD PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 2 WORLD PROBIOTICS MARKET, BY INGREDIENT, 2014–2022 ($MILLION)
TABLE 3 WORLD BACTERIA BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 4 WORLD YEAST BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 5 WORLD PROBIOTICS MARKET BY FUNCTION, 2014–2022 ($MILLION)
TABLE 6 WORLD REGULAR PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 7 WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 8 WORLD THERAPEUTIC PROBIOTICS BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 9 WORLD PROBIOTICS MARKET BY APPLICATION, 2014–2022 ($MILLION)
TABLE 10 WORLD FOOD & BEVERAGES PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 11 WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 12 WORLD ANIMAL FEED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 13 WORLD PROBIOTICS MARKET BY END USE, 2014–2022 ($MILLION)
TABLE 14 WORLD HUMAN PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 15 WORLD ANIMAL PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 16 NORTH AMERICA PROBIOTICS MARKET, BY APPLICATION, 2014–2022 ($MILLION)
TABLE 17 NORTH AMERICA PROBIOTICS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 18 EUROPE PROBIOTICS MARKET, BY APPLICATION, 2014–2022 ($MILLION)
TABLE 19 EUROPE PROBIOTICS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 20 ASIA-PACIFIC PROBIOTICS MARKET, BY APPLICATION, 2014–2022 ($MILLION)
TABLE 21 ASIA-PACIFIC PROBIOTICS MARKET, BY COUNTRY, 2015–2022 ($MILLION)
TABLE 22 LAMEA PROBIOTICS MARKET, BY APPLICATION, 2014–2022 ($MILLION)
TABLE 23 LAMEA PROBIOTICS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 24 YAKULT HONSHA CO., LTD. - COMPANY SNAPSHOT
TABLE 25 YAKULT HONSHA CO., LTD.- OPERATING SEGMENTS
TABLE 26 BIOGAIA AB - COMPANY SNAPSHOT
TABLE 27 BIOGAIA AB- OPERATING SEGMENTS
TABLE 28 DANONE - COMPANY SNAPSHOT
TABLE 29 DANONE - OPERATING SEGMENTS
TABLE 30 E. I. DU PONT DE NEMOURS AND COMPANY- COMPANY SNAPSHOT
TABLE 31 E. I. DU PONT DE NEMOURS AND COMPANY - OPERATING SEGMENTS
TABLE 32 PROBI AB - COMPANY SNAPSHOT
TABLE 33 PROBI AB - OPERATING SEGMENTS
TABLE 34 GANEDEN, INC - COMPANY SNAPSHOT
TABLE 35 GANEDEN, INC - OPERATING SEGMENTS
TABLE 36 PROTEXIN - COMPANY SNAPSHOT
TABLE 37 PROTEXIN - OPERATING SEGMENTS
TABLE 38 NESTLE S.A. - COMPANY SNAPSHOT
TABLE 39 NESTLE S.A.- OPERATING SEGMENTS
TABLE 40 CHR. HANSEN HOLDING A/S - COMPANY SNAPSHOT
TABLE 41 CHR. HANSEN HOLDING A/S- OPERATING SEGMENTS
TABLE 42 LIFEWAY FOODS, INC. - COMPANY SNAPSHOT
TABLE 43 LIFEWAY FOODS, INC. - OPERATING SEGMENTS
TABLE 1 WORLD PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 2 WORLD PROBIOTICS MARKET, BY INGREDIENT, 2014–2022 ($MILLION)
TABLE 3 WORLD BACTERIA BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 4 WORLD YEAST BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 5 WORLD PROBIOTICS MARKET BY FUNCTION, 2014–2022 ($MILLION)
TABLE 6 WORLD REGULAR PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 7 WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 8 WORLD THERAPEUTIC PROBIOTICS BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 9 WORLD PROBIOTICS MARKET BY APPLICATION, 2014–2022 ($MILLION)
TABLE 10 WORLD FOOD & BEVERAGES PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 11 WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 12 WORLD ANIMAL FEED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 13 WORLD PROBIOTICS MARKET BY END USE, 2014–2022 ($MILLION)
TABLE 14 WORLD HUMAN PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 15 WORLD ANIMAL PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 16 NORTH AMERICA PROBIOTICS MARKET, BY APPLICATION, 2014–2022 ($MILLION)
TABLE 17 NORTH AMERICA PROBIOTICS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 18 EUROPE PROBIOTICS MARKET, BY APPLICATION, 2014–2022 ($MILLION)
TABLE 19 EUROPE PROBIOTICS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 20 ASIA-PACIFIC PROBIOTICS MARKET, BY APPLICATION, 2014–2022 ($MILLION)
TABLE 21 ASIA-PACIFIC PROBIOTICS MARKET, BY COUNTRY, 2015–2022 ($MILLION)
TABLE 22 LAMEA PROBIOTICS MARKET, BY APPLICATION, 2014–2022 ($MILLION)
TABLE 23 LAMEA PROBIOTICS MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 24 YAKULT HONSHA CO., LTD. - COMPANY SNAPSHOT
TABLE 25 YAKULT HONSHA CO., LTD.- OPERATING SEGMENTS
TABLE 26 BIOGAIA AB - COMPANY SNAPSHOT
TABLE 27 BIOGAIA AB- OPERATING SEGMENTS
TABLE 28 DANONE - COMPANY SNAPSHOT
TABLE 29 DANONE - OPERATING SEGMENTS
TABLE 30 E. I. DU PONT DE NEMOURS AND COMPANY- COMPANY SNAPSHOT
TABLE 31 E. I. DU PONT DE NEMOURS AND COMPANY - OPERATING SEGMENTS
TABLE 32 PROBI AB - COMPANY SNAPSHOT
TABLE 33 PROBI AB - OPERATING SEGMENTS
TABLE 34 GANEDEN, INC - COMPANY SNAPSHOT
TABLE 35 GANEDEN, INC - OPERATING SEGMENTS
TABLE 36 PROTEXIN - COMPANY SNAPSHOT
TABLE 37 PROTEXIN - OPERATING SEGMENTS
TABLE 38 NESTLE S.A. - COMPANY SNAPSHOT
TABLE 39 NESTLE S.A.- OPERATING SEGMENTS
TABLE 40 CHR. HANSEN HOLDING A/S - COMPANY SNAPSHOT
TABLE 41 CHR. HANSEN HOLDING A/S- OPERATING SEGMENTS
TABLE 42 LIFEWAY FOODS, INC. - COMPANY SNAPSHOT
TABLE 43 LIFEWAY FOODS, INC. - OPERATING SEGMENTS
LIST OF FIGURES
FIG. 1 TOP IMPACTING FACTORS
FIG. 2 TOP WINNING STRATEGIES IN PROBIOTICS MARKET
FIG. 3 TOP WINNING STRATEGY ANALYSIS (% COMPARISON)
FIG. 4 TOP INVESTMENT POCKETS
FIG. 5 PORTER’S FIVE FORCES ANALYSIS
FIG. 6 VALUE CHAIN ANALYSIS OF PROBIOTICS MARKET
FIG. 7 MARKET SHARE ANALYSIS, 2015
FIG. 8 WORLD PROBIOTICS MARKET, BY INGREDIENT, 2014 & 2022 (% SHARE)
FIG. 9 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF BACTERIA BASED PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 10 WORLD BACTERIA BASED PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 11 WORLD BACTERIA BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 12 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF YEAST BASED PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 13 WORLD YEAST BASED PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 14 WORLD YEAST BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 15 WORLD PROBIOTICS MARKET, BY FUNCTION, 2014 & 2022 (% SHARE)
FIG. 16 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF REGULAR FUNCTION PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 17 WORLD REGULAR PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 18 WORLD REGULAR PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 (%)
FIG. 19 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF PREVENTIVE HEALTHCARE FUNCTION MARKET, 2014 & 2022 (%)
FIG. 20 WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 21 WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 (%)
FIG. 22 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF THERAPEUTIC FUNCTION IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 23 WORLD THERAPEUTIC PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 24 WORLD THERAPEUTIC PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 (%)
FIG. 25 WORLD PROBIOTICS MARKET, BY APPLICATION, 2014 & 2022 (% SHARE)
FIG. 26 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF FOOD & BEVERAGE SECTOR IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 27 WORLD FOOD & BEVERAGES PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 28 WORLD FOOD & BEVERAGE PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 29 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF DIETARY SUPPLEMENTS SECTOR IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 30 WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 31 WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 32 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF ANIMAL FEED SECTOR IN PROBIOTICS, 2014 & 2022 (%)
FIG. 33 WORLD ANIMAL FEED PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 34 WORLD ANIMAL FEED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 35 WORLD PROBIOTICS MARKET, BY END USE, 2014 & 2022 (% SHARE)
FIG. 36 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF HUMAN PROBIOTICS IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 37 WORLD HUMAN PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 38 WORLD HUMAN PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 39 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF ANIMAL PROBIOTICS IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 40 WORLD ANIMAL PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 41 WORLD ANIMAL PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 42 WORLD PROBIOTICS MARKET REVENUE, BY GEOGRAPHY (PERCENTAGE COMPARISON), 2015
FIG. 43 U.S. PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 44 MEXICO PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 45 CANADA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 46 UK PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 47 GERMANY PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 48 FRANCE PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 49 ITALY PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 50 REST OF EUROPE PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 51 CHINA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 52 JAPAN PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 53 INDIA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 54 REST OF ASIA-PACIFIC PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 55 LATIN AMERICA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 56 MIDDLE EAST PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 57 AFRICA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 58 YAKULT HONSHA CO., LTD.: NET SALES, 2012-2015 ($MILLION)
FIG. 59 YAKULT HONSHA CO., LTD: NET SALES BY BUSINESS SEGMENT (%), 2015
FIG. 60 YAKULT HONSHA CO., LTD: NET SALES BY GEOGRAPHY (%), 2015
FIG. 61 BIOGAIA AB: NET SALES, 2013-2015 ($MILLION)
FIG. 62 NET SALES: BIOGAIA AB, BY BUSINESS SEGMENT (%), 2015
FIG. 63 NET SALES: BIOGAIA AB, BY GEOGRAPHY (%), 2015
FIG. 64 DANONE: NET SALES, 2013-2015 ($MILLION)
FIG. 65 DANONE: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIG. 66 DANONE: NET SALES BY GEOGRAPHY (%), 2015
FIG. 67 E. I. DU PONT DE NEMOURS AND COMPANY: NET SALES, 2013-2015 ($MILLION)
FIG. 68 E. I. DU PONT DE NEMOURS AND COMPANY: NET SALES, BY SEGMENT (%), 2015
FIG. 69 PROBI AB: NET SALES, 2013- 2015 ($MILLION)
FIG. 70 PROBI AB: NET SALES BY BUSINESS SEGMENT (%), 2015
FIG. 71 PROBI AB: NET SALES BY GEOGRAPHY (%), 2015
FIG. 72 NESTLE S.A.: NET SALES, 2013-2015 ($MILLION)
FIG. 73 NESTLE S.A.: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIG. 74 NESTLE S.A.: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 75 CHR. HANSEN HOLDING A/S: NET SALES, 2013- 2015 ($MILLION)
FIG. 76 CHR. HANSEN HOLDING A/S: NET SALES BY BUSINESS SEGMENT (%), 2015
FIG. 77 CHR. HANSEN HOLDING A/S: NET SALES BY GEOGRAPHY (%), 2015
FIG. 78 LIFEWAY FOODS INC.: NET SALES, 2013- 2015 ($MILLION)
FIG. 79 LIFEWAY FOODS INC.: NET SALES BY BUSINESS SEGMENT (%), 2015
FIG. 80 LIFEWAY FOODS INC.: NET SALES BY GEOGRAPHY (%), 2015
FIG. 1 TOP IMPACTING FACTORS
FIG. 2 TOP WINNING STRATEGIES IN PROBIOTICS MARKET
FIG. 3 TOP WINNING STRATEGY ANALYSIS (% COMPARISON)
FIG. 4 TOP INVESTMENT POCKETS
FIG. 5 PORTER’S FIVE FORCES ANALYSIS
FIG. 6 VALUE CHAIN ANALYSIS OF PROBIOTICS MARKET
FIG. 7 MARKET SHARE ANALYSIS, 2015
FIG. 8 WORLD PROBIOTICS MARKET, BY INGREDIENT, 2014 & 2022 (% SHARE)
FIG. 9 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF BACTERIA BASED PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 10 WORLD BACTERIA BASED PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 11 WORLD BACTERIA BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 12 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF YEAST BASED PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 13 WORLD YEAST BASED PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 14 WORLD YEAST BASED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 15 WORLD PROBIOTICS MARKET, BY FUNCTION, 2014 & 2022 (% SHARE)
FIG. 16 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF REGULAR FUNCTION PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 17 WORLD REGULAR PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 18 WORLD REGULAR PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 (%)
FIG. 19 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF PREVENTIVE HEALTHCARE FUNCTION MARKET, 2014 & 2022 (%)
FIG. 20 WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 21 WORLD PREVENTIVE HEALTHCARE PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 (%)
FIG. 22 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF THERAPEUTIC FUNCTION IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 23 WORLD THERAPEUTIC PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 24 WORLD THERAPEUTIC PROBIOTICS MARKET BY GEOGRAPHY, 2014–2022 (%)
FIG. 25 WORLD PROBIOTICS MARKET, BY APPLICATION, 2014 & 2022 (% SHARE)
FIG. 26 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF FOOD & BEVERAGE SECTOR IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 27 WORLD FOOD & BEVERAGES PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 28 WORLD FOOD & BEVERAGE PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 29 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF DIETARY SUPPLEMENTS SECTOR IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 30 WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 31 WORLD DIETARY SUPPLEMENTS PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 32 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF ANIMAL FEED SECTOR IN PROBIOTICS, 2014 & 2022 (%)
FIG. 33 WORLD ANIMAL FEED PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 34 WORLD ANIMAL FEED PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 35 WORLD PROBIOTICS MARKET, BY END USE, 2014 & 2022 (% SHARE)
FIG. 36 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF HUMAN PROBIOTICS IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 37 WORLD HUMAN PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 38 WORLD HUMAN PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 39 COMPARATIVE REGIONAL MARKET SHARE ANALYSIS OF ANIMAL PROBIOTICS IN PROBIOTICS MARKET, 2014 & 2022 (%)
FIG. 40 WORLD ANIMAL PROBIOTICS MARKET REVENUE, 2014–2022 ($MILLION)
FIG. 41 WORLD ANIMAL PROBIOTICS MARKET, BY GEOGRAPHY, 2014–2022 (%)
FIG. 42 WORLD PROBIOTICS MARKET REVENUE, BY GEOGRAPHY (PERCENTAGE COMPARISON), 2015
FIG. 43 U.S. PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 44 MEXICO PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 45 CANADA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 46 UK PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 47 GERMANY PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 48 FRANCE PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 49 ITALY PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 50 REST OF EUROPE PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 51 CHINA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 52 JAPAN PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 53 INDIA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 54 REST OF ASIA-PACIFIC PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 55 LATIN AMERICA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 56 MIDDLE EAST PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 57 AFRICA PROBIOTICS MARKET, 2014–2022 ($MILLION)
FIG. 58 YAKULT HONSHA CO., LTD.: NET SALES, 2012-2015 ($MILLION)
FIG. 59 YAKULT HONSHA CO., LTD: NET SALES BY BUSINESS SEGMENT (%), 2015
FIG. 60 YAKULT HONSHA CO., LTD: NET SALES BY GEOGRAPHY (%), 2015
FIG. 61 BIOGAIA AB: NET SALES, 2013-2015 ($MILLION)
FIG. 62 NET SALES: BIOGAIA AB, BY BUSINESS SEGMENT (%), 2015
FIG. 63 NET SALES: BIOGAIA AB, BY GEOGRAPHY (%), 2015
FIG. 64 DANONE: NET SALES, 2013-2015 ($MILLION)
FIG. 65 DANONE: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIG. 66 DANONE: NET SALES BY GEOGRAPHY (%), 2015
FIG. 67 E. I. DU PONT DE NEMOURS AND COMPANY: NET SALES, 2013-2015 ($MILLION)
FIG. 68 E. I. DU PONT DE NEMOURS AND COMPANY: NET SALES, BY SEGMENT (%), 2015
FIG. 69 PROBI AB: NET SALES, 2013- 2015 ($MILLION)
FIG. 70 PROBI AB: NET SALES BY BUSINESS SEGMENT (%), 2015
FIG. 71 PROBI AB: NET SALES BY GEOGRAPHY (%), 2015
FIG. 72 NESTLE S.A.: NET SALES, 2013-2015 ($MILLION)
FIG. 73 NESTLE S.A.: NET SALES, BY BUSINESS SEGMENT (%), 2015
FIG. 74 NESTLE S.A.: NET SALES, BY GEOGRAPHY (%), 2015
FIG. 75 CHR. HANSEN HOLDING A/S: NET SALES, 2013- 2015 ($MILLION)
FIG. 76 CHR. HANSEN HOLDING A/S: NET SALES BY BUSINESS SEGMENT (%), 2015
FIG. 77 CHR. HANSEN HOLDING A/S: NET SALES BY GEOGRAPHY (%), 2015
FIG. 78 LIFEWAY FOODS INC.: NET SALES, 2013- 2015 ($MILLION)
FIG. 79 LIFEWAY FOODS INC.: NET SALES BY BUSINESS SEGMENT (%), 2015
FIG. 80 LIFEWAY FOODS INC.: NET SALES BY GEOGRAPHY (%), 2015
